# Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

> **NCT01245998** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 68 (actual)

## Conditions studied

- Superficial Thrombophlebitis

## Interventions

- **DRUG:** Dalteparin
- **DRUG:** Dalteparin

## Key facts

- **NCT ID:** NCT01245998
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-01
- **Primary completion:** 2012-12-03
- **Final completion:** 2014-01-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245998, "Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01245998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*